KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Finished Goods (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Finished Goods for 17 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 7.46% to $4.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, up 7.46% year-over-year, with the annual reading at $4.0 billion for FY2025, 7.46% up from the prior year.
  • Finished Goods hit $4.0 billion in Q4 2025 for Abbott Laboratories, down from $4.1 billion in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $4.3 billion in Q2 2025 to a low of $3.0 billion in Q3 2021.
  • Historically, Finished Goods has averaged $3.7 billion across 5 years, with a median of $3.9 billion in 2023.
  • Biggest five-year swings in Finished Goods: increased 23.5% in 2022 and later fell 6.23% in 2024.
  • Year by year, Finished Goods stood at $3.1 billion in 2021, then grew by 23.5% to $3.8 billion in 2022, then grew by 3.71% to $3.9 billion in 2023, then decreased by 6.23% to $3.7 billion in 2024, then grew by 7.46% to $4.0 billion in 2025.
  • Business Quant data shows Finished Goods for ABT at $4.0 billion in Q4 2025, $4.1 billion in Q3 2025, and $4.3 billion in Q2 2025.